SK284258B6 - Použitie 1-ar(alk)ylimidazolín-2-ónu na výrobu liečiva na ošetrovanie stavov strachu a napätia - Google Patents

Použitie 1-ar(alk)ylimidazolín-2-ónu na výrobu liečiva na ošetrovanie stavov strachu a napätia Download PDF

Info

Publication number
SK284258B6
SK284258B6 SK1584-99A SK158499A SK284258B6 SK 284258 B6 SK284258 B6 SK 284258B6 SK 158499 A SK158499 A SK 158499A SK 284258 B6 SK284258 B6 SK 284258B6
Authority
SK
Slovakia
Prior art keywords
formula
fear
group
compound
imidazolin
Prior art date
Application number
SK1584-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK158499A3 (en
Inventor
Angelika Rostock
Rita Dost
Christine Tober
Reni Bartsch
Klaus Unverferth
Chris Rundfeldt
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of SK158499A3 publication Critical patent/SK158499A3/sk
Publication of SK284258B6 publication Critical patent/SK284258B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1584-99A 1997-05-23 1998-05-14 Použitie 1-ar(alk)ylimidazolín-2-ónu na výrobu liečiva na ošetrovanie stavov strachu a napätia SK284258B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19721580A DE19721580A1 (de) 1997-05-23 1997-05-23 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
PCT/DE1998/001343 WO1998052548A2 (fr) 1997-05-23 1998-05-14 Utilisation de 1-ar(alk)yl-imidazolin-2-one pour le traitement de l'angoisse et du stress
US09/079,802 US5994347A (en) 1997-05-23 1998-05-15 For a process for treatment of anxiety and tension

Publications (2)

Publication Number Publication Date
SK158499A3 SK158499A3 (en) 2001-03-12
SK284258B6 true SK284258B6 (sk) 2004-12-01

Family

ID=26036759

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1584-99A SK284258B6 (sk) 1997-05-23 1998-05-14 Použitie 1-ar(alk)ylimidazolín-2-ónu na výrobu liečiva na ošetrovanie stavov strachu a napätia

Country Status (25)

Country Link
US (1) US5994347A (fr)
EP (1) EP0979083B1 (fr)
JP (1) JP4838403B2 (fr)
CN (1) CN1150901C (fr)
AR (1) AR012746A1 (fr)
AT (1) ATE246926T1 (fr)
AU (1) AU745536B2 (fr)
BG (1) BG63378B1 (fr)
BR (1) BR9809666A (fr)
CA (1) CA2291075C (fr)
DE (2) DE19721580A1 (fr)
DK (1) DK0979083T3 (fr)
ES (1) ES2205516T3 (fr)
HU (1) HUP0003108A3 (fr)
IL (1) IL132652A0 (fr)
NO (1) NO325346B1 (fr)
NZ (1) NZ500849A (fr)
PL (1) PL193589B1 (fr)
PT (1) PT979083E (fr)
RU (1) RU2203055C2 (fr)
SK (1) SK284258B6 (fr)
TR (1) TR199902815T2 (fr)
TW (1) TW579294B (fr)
WO (1) WO1998052548A2 (fr)
ZA (1) ZA984197B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CA2531861A1 (fr) * 2003-07-11 2005-01-20 Elbion Ag Methode de traitement ou de prevention de troubles du systeme nerveux central au moyen de composes a selectivite pour la sous-unite alpha 3 du recepteur des benzodiazepines
CA2576344C (fr) 2004-08-11 2010-10-05 Cadbury Adams Usa Llc Compositions de rechauffement et systemes de liberation associes
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
DE19532668A1 (de) * 1995-09-05 1997-03-06 Dresden Arzneimittel Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
US5869481A (en) * 1995-09-05 1999-02-09 Arzneitmittelwerk Dresden G.M.B.H. Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making

Also Published As

Publication number Publication date
ES2205516T3 (es) 2004-05-01
TR199902815T2 (xx) 2000-08-21
HUP0003108A2 (hu) 2001-05-28
PT979083E (pt) 2003-12-31
DK0979083T3 (da) 2003-12-01
WO1998052548A2 (fr) 1998-11-26
BG63378B1 (bg) 2001-12-29
NO325346B1 (no) 2008-04-07
DE59809285D1 (de) 2003-09-18
CA2291075A1 (fr) 1998-11-26
AU745536B2 (en) 2002-03-21
AR012746A1 (es) 2000-11-08
NO995300L (no) 1999-10-29
CA2291075C (fr) 2006-04-04
JP2001525829A (ja) 2001-12-11
NO995300D0 (no) 1999-10-29
ZA984197B (en) 1998-06-24
PL193589B1 (pl) 2007-02-28
IL132652A0 (en) 2001-03-19
PL337090A1 (en) 2000-07-31
WO1998052548A3 (fr) 1999-04-22
CN1260717A (zh) 2000-07-19
HUP0003108A3 (en) 2001-07-30
AU8332698A (en) 1998-12-11
SK158499A3 (en) 2001-03-12
NZ500849A (en) 2001-09-28
DE19721580A1 (de) 1998-11-26
ATE246926T1 (de) 2003-08-15
BR9809666A (pt) 2000-07-11
US5994347A (en) 1999-11-30
EP0979083B1 (fr) 2003-08-13
EP0979083A2 (fr) 2000-02-16
TW579294B (en) 2004-03-11
JP4838403B2 (ja) 2011-12-14
RU2203055C2 (ru) 2003-04-27
BG103859A (en) 2000-07-31
CN1150901C (zh) 2004-05-26

Similar Documents

Publication Publication Date Title
Krupitsky et al. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam
USRE36397E (en) Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity
Krystal et al. N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability
Simon et al. Anxiogenic-like effects induced by stimulation of dopamine receptors
SK7492002A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
Fritsch et al. Treatment of early and late kainic acid‐induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466
CA2761716A1 (fr) Traitement de troubles cognitifs avec certains recepteurs nicotiniques de type alpha-7 a en combinaison avec des inhibiteurs de l'acetylcholinesterase
US5474990A (en) Barbiturates as safening agents in conjunction with NMDA antagonists
Kesmati et al. Magnesium oxide nanoparticles reduce anxiety induced by morphine withdrawal in adult male mice
Fahim et al. Daily subacute paraquat exposure decreases muscle function and substantia nigra dopamine level
SK284258B6 (sk) Použitie 1-ar(alk)ylimidazolín-2-ónu na výrobu liečiva na ošetrovanie stavov strachu a napätia
Kulkarni et al. Animal models of tardive dyskinesia
Palmer et al. The Low‐Affinity, Use‐Dependent NMDA Receptor Antagonist AR‐R 15896AR: An Update of Progress in Stroke
Escubedo et al. Involvement of nicotinic receptors in methamphetamine-and MDMA-induced neurotoxicity: pharmacological implications
CZ9904182A3 (cs) Užití 1-aralkylimidazolin 2-onu pro léčení stavů úzkosti a stresů
KR100577626B1 (ko) 1-아르(알크)일-이미다졸린-2-온을 포함하는, 불안 치료용 약제학적 조성물
Prus et al. Acute nicotine reduces and repeated nicotine increases spontaneous activity in male and female Lewis rats
Dhole et al. Comparison of anxiolytic activity of ondansetron and ursolic acid with diazepam in acute anxiety
Acuña et al. Promising immunomodulators for management of substance and alcohol use disorders
MXPA99010609A (en) Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
SAYIN et al. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats
Battaglia et al. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia
Vesali Mahmood et al. The interaction of levetiracetam’s analgesia with morphine induced tolerance in tail-flick mice model
CZ2003234A3 (cs) 2-Aryl-8-oxodihydropurinové deriváty jako léčivo
RABANI et al. Acute and chronic effects of nitrendipine on naloxone precipitated morphine withdrawal in mice

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100514